McKesson
$167.639876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$167.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.40 (-0.24%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell McKesson and other stocks, options, ETFs, and crypto commission-free!
About MCK
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Read More Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
Employees
80,000
Headquarters
Irving, Texas
Founded
1833
Market Cap
29.75B
Price-Earnings Ratio
—
Dividend Yield
0.98
Average Volume
3.86M
High Today
$169.03
Low Today
$166.82
Open Price
$168.56
Volume
5.20M
52 Week High
$169.67
52 Week Low
$110.52
Collections
Analyst Ratings
37%
of 19 ratings
Buy
37%
Hold
63%
Sell
0%
MCK Earnings
$2.88
$3.19
$3.50
$3.81
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
$3.56 per share
Actual
$3.81 per share
People Also Bought
CVS
22,714
$71.95
+0.81%Gilead Sciences
15,820
$67.55
-0.01%AT&T
105,384
$38.25
0.00%Pfizer
33,512
$36.30
-0.58%Walgreens
7,769
$51.86
-1.02%Exxon Mobil
24,400
$59.96
-1.14%IBM
12,970
$151.15
+0.30%Kraft Foods
20,495
$27.40
+1.93%Cardinal Health
2,156
$59.01
-1.02%Bristol-Myers Squibb
7,849
$66.20
-0.27%3M
14,795
$158.95
-1.28%Johnson & Johnson
21,440